NEW YORK (GenomeWeb News) – Scientists at Harvard Medical School and its related institutions will use Exiqon's Locked Nucleic Acid microRNA Knockdown Library for high-throughput screening of small molecule and RNAi libraries, the Danish company said today.
Under the agreement, Harvard's ICCB-Longwood Screening Facility will serve as a microRNA Screening Center of Excellence, enabling it to provide the Exiqon technology to a new consortium of investigators at and affiliated with Harvard.
The Knockdown Library contains more than 900 specific inhibitors, and it incorporates Exiqon's LNA detection technology.
"There is a great deal of interest in our community in using miRNA knockdown reagents to study disease-related biology," Neil Kubica, a research fellow in cell biology at Harvard Medical School and the consortium's coordinator, said in a statement.
Financial terms of the agreement were not released.